Liberation de Leon
Pediatrics · Paramount, CANPI 1912120379
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations.
Across 62 payments — averaging $20.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$267
- Pfizer$239
- GSK$183
- Sanofi Pasteur Inc.$146
- Cranial Technologies, Inc$127
- Roche Diagnostics Corporation$100
- plus $190 from 6 others
Across 262 payments — averaging $10,175 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$1.9M
- AbbVie$563K
- AstraZeneca$85K
- Teva Pharmaceuticals USA, Inc.$45K
- Sanofi Pasteur Inc.$38K
- Astrazeneca UK Limited$7K
What the payments were for
- Consulting fees$252%
- Food & beverage$1,22798%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 15 | $267 |
| Pfizer | 12 | $239 |
| GSK | 10 | $183 |
| Sanofi Pasteur Inc. | 8 | $146 |
| Cranial Technologies, Inc | 8 | $127 |
| Roche Diagnostics Corporation | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| Seqirus USA Inc | 2 | $34 |
| Azurity Pharmaceuticals, Inc. | 1 | $32 |
| AstraZeneca | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Phadia US Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,252 in reported general payments places this provider in the 85th percentile of 5,539 pediatrics providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azithromycin | 11 | $119 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Paramount
- Laurene MascolaLos Angeles$451K
- Tonya ChaffeeSan Francisco$359K
- Anthony PortaleSan Francisco$354K
- David KesslerSan Francisco$335K
- Lawrence SherRolling Hills Estates$297K
- Steven BlackOakland$228K
- Jonathan StroberSan Francisco$164K
- Hasmukh AminBakersfield$140K
- Colleen KraftNewport Beach$122K
- Lela BachrachOakland$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.